QTERN cpr pell 5mg/10mg 28 pce

7680660400018 CH-66040 A10BD21 07.06.2.

Reimbursement limitations:

OZEMPIC.01

Pour le traitement des patients atteints d’un diabète sucré de type 2 insuffisamment contrôlé en …

QTERN cpr pell 5mg/10mg 28 pce
QTERN cpr pell 5mg/10mg 28 pce
QTERN cpr pell 5mg/10mg 28 pce
1 / 3
google

Details

Product number
6604001
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
dapagliflozinum 10 mg ut dapagliflozinum propandiolum monohydricum, saxagliptinum 5 mg ut saxagliptini hydrochloridum, cellulosum microcristallinum, lactosum 40 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidum hydrochloridum, natrii hydroxidum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: E 132, lacca, pro compresso obducto corresp. natrium max. 0.91 mg.

Articles (1)

Qtern, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/09/2026
Professional SmPC
Français
25/09/2026
Professional SmPC
Italien
25/09/2026
Patient information leaflet
Allemand
28/05/2024
Patient information leaflet
Français
28/05/2024
Patient information leaflet
Italien
28/05/2024

Detailed composition

Substance Quantity Type Category
dapagliflozinum
10.0 MG Substance Wirkstoff (Principe actif)
dapagliflozinum propylenglycolum monohydricum
- Substance WIZUS
saxagliptinum
5.0 MG Substance Wirkstoff (Principe actif)
saxagliptini hydrochloridum
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
lactosum
40.0 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 132
- Substance FIMDK
lacca
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 91.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2017

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
66040
Drug name
Qtern, Filmtabletten
Galenic form
FILM
ATC Code
A10BD21
Authorization status
Z
Dispensation category
B
First authorization
26/06/2017
Authorization expiration date
31/12/9999
IT number
07.06.2.
Domain
Human medicine
Field of application
Antidiabetikum

Packaging details

Description (FR)
QTERN cpr pell 5mg/10mg 28 pce
Description (DE)
QTERN Filmtabl 5mg/10mg 28 Stk
Market launch
26/06/2017
Narcotic (BTM)
No

Other packaging sizes

QTERN cpr pell 5mg/10mg 98 pce
98 TABL
View
Buy us a coffee Explore the data